Cicalese, Maria Pia (2015) New approaches in management and treatment of primary immunodeficiencies and other genetic diseases. [Tesi di dottorato]
Preview |
Text
cicalese_mariapia_27-2.pdf Download (36MB) | Preview |
Item Type: | Tesi di dottorato |
---|---|
Resource language: | English |
Title: | New approaches in management and treatment of primary immunodeficiencies and other genetic diseases. |
Creators: | Creators Email Cicalese, Maria Pia mariapia.cicalese@tiscali.it |
Date: | 30 March 2015 |
Number of Pages: | 312 |
Institution: | Università degli Studi di Napoli Federico II |
Department: | Scienze Mediche Traslazionali |
Scuola di dottorato: | Medicina clinica e sperimentale |
Dottorato: | Riproduzione, sviluppo ed accrescimento dell'uomo |
Ciclo di dottorato: | 27 |
Coordinatore del Corso di dottorato: | nome email Pignata, Claudio pignata@unina.it |
Tutor: | nome email Pignata, Claudio UNSPECIFIED |
Date: | 30 March 2015 |
Number of Pages: | 312 |
Keywords: | Primary immunodeficiencies, gene therapy, Duchenne Muscular Dystrophy, cellular therapy, bone marrow transplantation, children. |
Settori scientifico-disciplinari del MIUR: | Area 05 - Scienze biologiche > BIO/10 - Biochimica Area 05 - Scienze biologiche > BIO/12 - Biochimica clinica e biologia molecolare clinica Area 05 - Scienze biologiche > BIO/13 - Biologia applicata Area 06 - Scienze mediche > MED/07 - Microbiologia e microbiologia clinica Area 06 - Scienze mediche > MED/15 - Malattie del sangue Area 06 - Scienze mediche > MED/38 - Pediatria generale e specialistica |
Additional information: | Il mio programma di dottorato è stato svolto presso HSR TIGET (San Raffaele Institute for Gene Therapy) di Milano. Pertanto, oltre al tutor, Prof. Claudio Pignata, sarà presente quale co-tutor da HSR-TIGET il Prof. Alessandro Aiuti. |
Date Deposited: | 10 Apr 2015 12:36 |
Last Modified: | 23 Apr 2018 01:00 |
URI: | http://www.fedoa.unina.it/id/eprint/10131 |
DOI: | 10.6093/UNINA/FEDOA/10131 |
Collection description
During my PhD program in "Human Reproduction, Development and Growth" (XXVII Cycle, years 2011-2014), I contributed to the development of new approaches for the treatment of PIDs and other genetic diseases by advanced therapies, such as gene and cellular therapy. Moreover, I participated in the clinical and biological characterization of patients with immunodeficiencies and in the implementation of new approaches for the clinical management of children affected by hematological and immunological disorders undergoing bone marrow transplantation. My other lines of research have been focused on the use of new drugs in pediatric population, characterization of severe and unusual conditions and description of the State of the Art of known patologies in childhood.
Downloads
Downloads per month over past year
Actions (login required)
View Item |